Electrocore (NASDAQ:ECOR) is a health technology company focused on developing and commercializing a range of non-invasive vagus nerve stimulation (nVNS) therapies for the treatment of various conditions including migraine, cluster headache, and potentially other disorders. Their flagship product, gammaCore, is designed to provide patients with a drug-free alternative for the acute treatment of episodic and chronic cluster headaches and migraine. Consistently exploring advancements in neuromodulation, Electrocore aims to expand its applications and explore further medical conditions that could benefit from nVNS therapy. With a commitment to innovation and patient care, Electrocore strives to improve the quality of life for individuals suffering from these debilitating conditions by providing effective, accessible, and safe therapy options.